Bristol-Myers Squibb Company reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales wa...
Mutchlerinc Competitors or Alternatives
Mutchlerinc's top competitors include Freedom Pharmaceuticals, BioSpectra and Rochem International.
Mutchlerinc VS Freedom Pharmaceuticals
Freedom Pharmaceuticals is seen as one of Mutchlerinc's biggest rivals. Freedom Pharmaceuticals is headquartered in Broken Arrow, Oklahoma, and was founded in 2010. Like Mutchlerinc, Freedom Pharmaceuticals also works within the Pharmaceuticals sector. Freedom Pharmaceuticals generates 82% the revenue of Mutchlerinc.
Mutchlerinc VS BioSpectra
BioSpectra is seen as one of Mutchlerinc's top competitors. BioSpectra was founded in 1994, and its headquarters is in Bangor, Pennsylvania. BioSpectra operates in the Specialty Chemicals industry. BioSpectra has 79 fewer employees than Mutchlerinc.
Mutchlerinc VS Rochem International
Rochem International is one of Mutchlerinc's top rivals. Rochem International is a Private company that was founded in Hauppauge, New York in 1994. Rochem International operates in the Pharmaceuticals industry. Rochem International has 46 fewer employees vs. Mutchlerinc.
Looking for similar companies to Mutchlerinc?
Similar Companies
Pharmaceuticals companies in New Jersey
See 708 companies
Pharmaceuticals & Biotechnology companies in New JerseySee 1,085 companies
Pharmaceuticals companies with revenue in $25-100M rangeSee 828 companies
Pharmaceuticals companies in New York Metropolitan AreaSee 1,035 companies
Pharmaceuticals companies with employees in 100-250 rangeSee 815 companies
Pharmaceuticals & Biotechnology companies with revenue in $25-100M rangeSee 1,457 companies
Pharmaceuticals & Biotechnology companies in New York Metropolitan AreaSee 1,762 companies
Pharmaceuticals & Biotechnology companies with employees in 100-250 rangeSee 1,805 companies
Pharmaceuticals companies in USASee 8,289 companies
Trending News for Mutchlerinc and Mutchlerinc's Competitors
In This Article: GALWAY , Ireland , April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced...
Lilly accuses four compounders of selling unauthorized versions of the pharma giant's diabetes and weight-loss drugs....
EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec announces significant progress in strategic protein degradation collaboration with Bristol Myer...
Deep-pocketed investors have adopted a bullish approach towards Eli Lilly (NYSE:LLY), and it's something market players shouldn't ignore. Our tracking ...
Grove Biopharma, a Chicago, IL-based private biotechnology company providing its Bionic Biologics platform, raised $30M in Series A funding...
Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first heal...
The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump's planned pharmaceutical tariff...
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeSty...
Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the June 6th expiration. At Stock Options Channel, our YieldBoo...
Frequently Asked Questions about Mutchlerinc
Who are Mutchlerinc's top competitors?
Mutchlerinc's top 3 competitors are Freedom Pharmaceuticals, BioSpectra, Rochem International.Who is similar to Mutchlerinc?
Freedom Pharmaceuticals is the most similar to Mutchlerinc. BioSpectra and Rochem International are also similar to Mutchlerinc.
Are Mutchlerinc and Freedom Pharmaceuticals competitors?
Yes, Freedom Pharmaceuticals is one of Mutchlerinc’s top competitors.